UroGen Pharma Ltd. — Director's Dealing 2021

Jul 12, 2021

SEC Form 4/A — Form 4/A

Issuer: UroGen Pharma Ltd. (URGN)
CIK: 0001668243
Period of Report: 2020-06-03

Reporting Person: Barrett Elizabeth A. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-03	Ordinary Shares	M	8807	—	Acquired	166272	Direct
2020-07-03	Ordinary Shares	M	8807	—	Acquired	175079	Direct
2020-08-03	Ordinary Shares	M	8807	—	Acquired	183886	Direct
2020-09-03	Ordinary Shares	M	8807	—	Acquired	192693	Direct
2020-10-03	Ordinary Shares	M	8808	—	Acquired	201501	Direct
2020-11-03	Ordinary Shares	M	8808	—	Acquired	210309	Direct
2020-12-03	Ordinary Shares	M	8808	—	Acquired	219117	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-03	Restricted Stock Units	$	M	8807	Disposed		Ordinary Shares (8807)	Direct
2020-07-03	Restricted Stock Units	$	M	8807	Disposed		Ordinary Shares (8807)	Direct
2020-08-03	Restricted Stock Units	$	M	8807	Disposed		Ordinary Shares (8807)	Direct
2020-09-03	Restricted Stock Units	$	M	8807	Disposed		Ordinary Shares (8807)	Direct
2020-10-03	Restricted Stock Units	$	M	8808	Disposed		Ordinary Shares (8808)	Direct
2020-11-03	Restricted Stock Units	$	M	8808	Disposed		Ordinary Shares (8808)	Direct
2020-12-03	Restricted Stock Units	$	M	8808	Disposed		Ordinary Shares (8808)	Direct

Footnotes

F1: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020.

F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years.